Sharing perspectives leads to greater understanding and fuels innovation.
The Optum Insights blog is where we share our perspective and challenge preconceptions to clear a new path forward.
|
September 29, 2020 · Clinical Team
The U.S. Food and Drug Administration (FDA) has issued a labeling change requiring the Boxed Warning and other precautions included in prescribing information to be updated for all benzodiazepines. Read more... |
|
|
September 23, 2020 · Clinical Team
The U.S. Food and Drug Administration (FDA) announced that Perrigo Pharmaceutical Company issued a voluntary recall for all unexpired albuterol sulfate inhalation aerosol to the retail level. The September 21, 2020 recall announcement was issued due to the potential clogging of the inhaler, which could result in health risks to patients if they do not receive enough or any medication when using the inhaler. Read more... |
|
September 23, 2020 · Optum Workers' Comp and Auto No-fault
An Amerisure claimant needed a new prosthetic leg, so Amerisure reached out to get a quote from the vendor that provided the claimant’s last prosthetic in 2018. Amerisure sent that quote to their partner Optum to verify if the quote was reasonable and the particular prosthetic was clinically appropriate. Read more... |
|
September 20, 2020 · Policy Matters team
Listed below are brief updates on several recent policy developments across the country. Read more... |
|
|
September 14, 2020 · Clinical Team
The U.S. Food and Drug Administration (FDA) has issued a safety communication regarding the use of hot/cold therapy devices. The September 9, 2020 communication reminds patients and healthcare providers about the importance of following the instructions when providing cold therapy through a water-circulating hot/cold therapy device. Read more... |
|
|
September 10, 2020 · Optum Workers' Comp and Auto No-fault
ODG has been making changes to treatment guidelines. Optum is following suit by changing some of our program parameters. Beginning September 23, 2020, Optum is lowering our opioid alerting parameter to 90 mg of oral morphine equivalents (morphine equivalent dose, or MED) for treating chronic pain. Read more... |
|
September 03, 2020 · Public Policy & Regulatory Affairs Team
In the late hours of the legislative session, the California Assembly and Senate reached a compromise and passed a COVID-19 workers’ compensation presumption bill. After considering several various pieces of presumption legislation, the Legislature passed SB 1159, which creates a presumption and addresses the impact of COVID-19 on the workers’ compensation system. It is expected to be signed by the governor. Read more... |
|
|
August 30, 2020 · Policy Matters team
Listed below are brief updates on several recent policy developments across the country. Read more... |
Page 1 of 12
Subscribe today to receive our latest blogs, articles and more.
